Pkib involved in the metastasis and survival of osteosarcoma

HIGHLIGHTS

• who: Rongxue Wan from the Chengdu Medical College, China Guizhou Medical University, China have published the article: PKIB involved in the metastasis and survival of osteosarcoma, in the Journal: (JOURNAL)
• what: Systemic metastasis is still the major reason for poor prognosis in patients with osteosarcoma, with approximately 20% of cases being reported metastatic at diagnosis . According to the model obtained, the authors could predict the 1-, 2-, 3-, and 5-year survival rates of patients with expression patterns of AIM2 and PKIB.
• how: The authors also performed the wound-healing assay to compare . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.